MedX Health Corp

Equities

MDX

CA5850901037

Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 10:16:01 2024-04-30 am EDT			5-day change	1st Jan Change
0.09 ^CAD	-10.00%		-5.26%	+50.00%

Feb. 28	MedX Health Corp. and Health Partners Group Limited Announce Successful Results of its Pilot Project in the United Kingdom and Move Towards A Partnership Agreement	CI
2023	MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

MedX Health Corp Auditor Raises 'Going Concern' Doubt

May 30, 2023

MedX Health Corp filed its Annual on May 01, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kreston GTA LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about MedX Health Corp

MedX Health Corp. and Health Partners Group Limited Announce Successful Results of its Pilot Project in the United Kingdom and Move Towards A Partnership Agreement	Feb. 28	CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
MedX Health Corp announced that it has received CAD 1.02 million in funding	Nov. 13	CI
MedX Health Corp. Announcing Proposed Extension of Non-Brokered Private Placement Offering	23-10-12	MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding	23-08-29	CI
MedX Health Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
MedX Health Corp. Brief: Appointing Stephen Lockyer as CEO	23-05-10	MT
MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director	23-05-10	CI
MedX Health Corp. Announces Chief Executive Officer Changes	23-05-10	CI
MedX Health Corp Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI
MedX Health Corp Auditor Raises 'Going Concern' Doubt	23-04-30	CI
MedX Health Details Board Changes	23-04-25	MT
MedX Health Corp Announces Board Changes	23-04-25	CI
MedX Health, PharmaChoice Enter MOU to Launch MedX Teledermatology Screening Platform Across Canada	23-04-18	MT
MedX Health Corp and Pharmachoice Announces Agreement to Launch Medx Teledermatology Screening Platform Across Canada	23-04-18	CI
MedX Health Corp announced that it has received CAD 1.465 million in funding from Forest Lane Holdings Limited	23-03-16	CI
MedX Health Plans to Undertake $1.5 Million Convertible Debenture Financing	23-01-30	MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited	23-01-29	CI
MedX Health Corp announced that it has received CAD 1.5 million in funding from Forest Lane Holdings Limited	23-01-05	CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited	22-11-17	CI
MedX Health Corp announced that it has received CAD 1.1 million in funding	22-10-20	CI
MedX Health Corp announced that it has received CAD 1.1 million in funding from Forest Lane Holdings Limited and other investors	22-10-20	CI
MedX Health Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI

Chart MedX Health Corp

Duration

Period

More charts

Company Profile

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-29 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDX HEALTH CORP	+50.00%	19.19M
THERMO FISHER SCIENTIFIC	+7.75%	220B
DANAHER CORPORATION	+6.39%	183B
INTUITIVE SURGICAL, INC.	+10.57%	133B
BOSTON SCIENTIFIC CORPORATION	+24.33%	107B
SIEMENS HEALTHINEERS AG	-0.95%	63.05B
EDWARDS LIFESCIENCES CORPORATION	+11.36%	51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.47B
AGILENT TECHNOLOGIES, INC.	-1.04%	40.91B
RESMED, INC.	+24.21%	31.91B

Other Advanced Medical Equipment & Technology